Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
NeuroRehabilitation ; 42(1): 53-61, 2018.
Article in English | MEDLINE | ID: mdl-29400674

ABSTRACT

BACKGROUND: The search for reliable techniques to assess gait in stroke patients is crucial for the design and follow-up of rehabilitation programs. OBJECTIVE: To assess the reproducibility of kinematic and kinetic gait parameters in chronic stroke patients using a three-dimensional gait analysis system. METHODS: Ten chronic stroke patients were assessed while walking along a 20 m walkway at their natural speed, using a gait analysis system of six infrared cameras and two force plates. Each patient performed 10 gait trials on 2 separate days. Inter-measurement agreement was assessed with the Coefficient of Multiple Correlation, while Root Mean Square Differences were used to quantify the variability of the trials. RESULTS: The majority of kinetics and kinematics showed excellent reproducibility in all patients. Joints' power seemed to be more reliable compared with joints' angle and moment. Most parameters presented greater variability in non-paretic than the paretic leg, while they were less variable in the sagittal compared with the non-sagittal planes. Less than 10 trials were sufficient to obtain excellent reproducibility for most kinematic and kinetic parameters. CONCLUSIONS: The reproducibility of movement assessment through three-dimensional gait analysis appears excellent in chronic stroke patients.


Subject(s)
Gait , Neurologic Examination/methods , Stroke/physiopathology , Aged , Biomechanical Phenomena , Female , Humans , Male , Middle Aged , Neurologic Examination/standards , Reproducibility of Results , Stroke/diagnosis
2.
Eur J Gastroenterol Hepatol ; 25(5): 539-42, 2013 May.
Article in English | MEDLINE | ID: mdl-23255024

ABSTRACT

AIM: Peripheral neuropathy is often described in inflammatory bowel disease (IBD). The aim of this study was to assess the need for neurophysiological testing in IBD patients without neurological symptoms or signs to detect early subclinical neuropathy and its possible correlations with clinical and demographic characteristics. MATERIALS AND METHODS: Ninety-seven consecutive IBD patients were screened for neurological symptoms and clinical signs, and those without symptoms or signs were included. Also, patients with comorbidities associated with peripheral neuropathy or a history of neurological disease were excluded. The remaining 45 asymptomatic patients were tested electrophysiologically for peripheral nerve involvement. RESULTS: None of the examined patients showed evidence for subclinical neuropathy. CONCLUSION: IBD patients with a normal neurological clinical examination and no symptoms have no evidence for neuropathy. Therefore, proper electrophysiological testing is not considered necessary.


Subject(s)
Inflammatory Bowel Diseases/complications , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/etiology , Adolescent , Adult , Aged , Female , Humans , Inflammatory Bowel Diseases/physiopathology , Male , Mass Screening/methods , Middle Aged , Motor Neurons/physiology , Neural Conduction/physiology , Neurologic Examination/methods , Peripheral Nervous System Diseases/physiopathology , Sensory Receptor Cells/physiology , Severity of Illness Index , Unnecessary Procedures , Young Adult
3.
J Diabetes Complications ; 21(6): 353-8, 2007.
Article in English | MEDLINE | ID: mdl-17967706

ABSTRACT

OBJECTIVE: The objective of this study was to evaluate the sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients as compared with clinical examination and nerve conduction study (NCS). PATIENTS AND METHODS: This study included 120 type 2 diabetes patients (58 men) with a mean age of 67.3 +/- 5.9 years and a mean diabetes duration of 13.1 +/- 3.2 years. Diabetic neuropathy was diagnosed through the Neuropathy Disability Score. An NCS was performed on radial, ulnar, sural, and common and deep peroneal nerves. Patients were also examined with the new indicator test. The "time to complete color change of the test" from blue to pink was recorded. The test was considered abnormal in patients who exhibited a time to complete color change of the test exceeding 600 s in at least one foot. RESULTS: Neuropathy was diagnosed by clinical examination in 83 (69.2%) patients. The sensitivity of the indicator test for clinical neuropathy was 95.2%, and its specificity was 67.6%. The sensitivity of NCS for clinical neuropathy was 94%, and its specificity was 62.1%. The sensitivity of the indicator test for abnormal NCS was 97.8%, and its specificity was 96.4%. CONCLUSIONS: The new indicator test has a very high sensitivity not only for the diagnosis of clinical neuropathy but also for the diagnosis of neurophysiological neuropathy. Specificity is moderately high for the diagnosis of clinical neuropathy, while it is particularly high for the diagnosis of neurophysiological neuropathy. The indicator test has a validity comparable to that of NCS for the diagnosis of diabetic neuropathy. Finally, the time to complete color change of the test is associated with the severity of nerve conduction impairment.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetic Neuropathies/diagnosis , Neural Conduction/physiology , Peripheral Nervous System Diseases/diagnosis , Reagent Kits, Diagnostic , Skin Pigmentation/physiology , Aged , Diabetic Neuropathies/physiopathology , Female , Humans , Male , Middle Aged , Patient Selection , Peripheral Nervous System Diseases/physiopathology , Reproducibility of Results , Sensitivity and Specificity
4.
Eur J Gastroenterol Hepatol ; 19(2): 159-62, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17273002

ABSTRACT

Therapies aimed at inhibiting tumour necrosis factor are currently successfully administered to an increasing number of patients with autoimmune diseases. Infliximab has been approved to induce and maintain remission in Crohn's disease and fistulizing Crohn's disease. We report a case of acute-onset flaccid paraplegia after the initiation of anti-tumour necrosis factor therapy (infliximab) for Crohn's disease. Neuroimaging findings revealed an extensive longitudinal myelopathy. Two months later, no abnormal signal intensity was observed in the spinal cord and after 4 months, the patient presented improvement of motor function. A possible correlation between anti-tumour necrosis factor therapy and acute myelitis is discussed. This case highlights that patients developing new neurological symptoms while on anti-tumour necrosis factor medication should be monitored closely.


Subject(s)
Antibodies, Monoclonal/adverse effects , Crohn Disease/drug therapy , Gastrointestinal Agents/adverse effects , Paraplegia/chemically induced , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Acute Disease , Adult , Humans , Infliximab , Magnetic Resonance Imaging , Male , Myelitis/chemically induced , Myelitis/diagnosis
5.
Qual Life Res ; 15(5): 833-9, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16721643

ABSTRACT

This study is presenting the translation and cultural adaptation into Greek of the Quality of Life in Epilepsy Inventory (QOLIE-31). We adapted the QOLIE-31 to Greek through a procedure of translation-back-translation. Sixty-three patients were interviewed and completed the QOLIE-31 and the GHQ questionnaires. We re-examined a subset of them after a period of 2-5 weeks to evaluate the test-retest reliability of the questionnaire. We assessed the convergent validity by comparison of the QOLIE-31 and the GHQ and QOLIE-31 subscales and external measures. Discriminative validity was evaluated using the method of known-groups comparisons. The internal consistency was high for the QOLIE-31 and its' subscales (Cronbach's alpha 0.92 and 0.59-0.83 respectively). Test-retest reliability was acceptable (intra-class correlation coefficient 0.49-0.89 and Pearson's coefficient 0.53-0.92) for the group of patients who were re-examined. Comparison of the QOLIE-31 and GHQ scores showed agreement between the two questionnaires (Pearson's coefficient -0.61). We demonstrated the discriminative validity by the difference in the QOLIE-31 scores between patients with different seizure frequencies and different employment status. We concluded that the Greek version of the QOLIE-31 has psychometric properties equivalent to those of the original American-English version and is a valid and reliable instrument.


Subject(s)
Epilepsy/psychology , Quality of Life , Surveys and Questionnaires , Adolescent , Adult , Aged , Anticonvulsants , Female , Greece , Humans , Male , Middle Aged , Psychometrics
6.
Brain Topogr ; 17(2): 117-23, 2004.
Article in English | MEDLINE | ID: mdl-15754877

ABSTRACT

BACKGROUND AND PURPOSE: Non linear signal analysis is a powerful technique that reveals qualitative and quantitative differentiations between different dynamical systems (biological or otherwise). Presented here are the first results of a work in progress to investigate the Magnetoencephalograms (MEG) from patients with malignant CNS lesions and from healthy volunteers. METHODS: We present MEG recordings of 10 patients diagnosed with malignant CNS lesions and the corresponding ones from 10 healthy volunteers. A 122-channel SQUID biomagnetometer in an electromagnetically shielded room was used to record the MEG signals and the Grassberger-Procaccia method for the estimation of the correlation dimension was applied on the phase space reconstruction of the recorded signal from each patient. RESULTS: Evidence linking MEG signal characteristics (existence of low dimensionality chaotic dynamics) with the existence of the tumour was found from this analysis. CONCLUSION: The obtained results substantiate our hypothesis of a relation between tumours of the brain and the mathematically chaotic nature of the neural dynamics derived from their MEG recordings.


Subject(s)
Brain Mapping , Brain Neoplasms/physiopathology , Nonlinear Dynamics , Aged , Electroencephalography/methods , Female , Humans , Magnetoencephalography/methods , Male , Middle Aged
7.
Muscle Nerve ; 27(6): 715-9, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12766983

ABSTRACT

Assessment of respiratory muscle weakness is important at all stages of myasthenia gravis. The maximal voluntary ventilation (MVV) is an objective dynamic method for measuring the working capacity of respiratory muscles. The clinical value of this method was studied in 24 newly diagnosed patients with myasthenia gravis, classified according to Osserman criteria (grades I, IIa, and IIb). The MVV values were normal in group I, whereas a characteristic "myasthenic pattern" of decremental respiratory volumes was demonstrated during MVV in group IIa and IIb patients, with or without dyspnea. Despite some limitations and lack of specificity, MVV may be a valuable tool in the assessment of respiratory dysfunction in patients with myasthenia gravis. Muscle Nerve, 27: 715-719, 2003


Subject(s)
Myasthenia Gravis/physiopathology , Respiratory Paralysis/etiology , Respiratory Paralysis/physiopathology , Ventilators, Mechanical , Adrenal Cortex Hormones/therapeutic use , Adult , Cholinesterase Inhibitors/therapeutic use , Female , Humans , Male , Middle Aged , Respiratory Muscles/physiopathology , Respiratory Paralysis/drug therapy
8.
Eur Neurol ; 49(1): 8-12, 2003.
Article in English | MEDLINE | ID: mdl-12464712

ABSTRACT

The frequency of multiple sclerosis (MS) in Greece is still debated. Our previous epidemiological field survey with a cross-check study of MS on March 31, 1984, in the province of Evros in north-eastern Greece showed a prevalence rate of 10.1/100,000. In 1990, Milonas et al. recorded a prevalence rate of 29.5/100,000 in northern Greece. So Greece is classified in the medium-frequency zone according to Kurtzke. This study was performed to estimate the prevalence of MS in the province of Evros and the annual incidence rates from 1974 to 1999. Patients were identified from several sources. A clinical follow-up was performed in 95% of the cases, and, if clinically indicated, new paraclinical examinations were performed and cases classified by Poser's criteria. The prevalence rate of the definite MS cases on December 31, 1999, was 38.9/100,000 and places the area in the high-risk zone. The mean annual incidence measured in 5-year intervals increased from 0.66/100,000 in 1974-1978 to 2.36/100,000 in 1994-1999 (p < 0.01). The increase in prevalence can be attributed to other causes than etiological changes, but the increase in the annual incidence rate indicates the possibility of a variation in risk factors of the disease.


Subject(s)
Multiple Sclerosis/epidemiology , Adult , Cross-Sectional Studies , Female , Greece/epidemiology , Health Surveys , Humans , Incidence , Male , Middle Aged , Multiple Sclerosis/diagnosis , Multiple Sclerosis/etiology , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...